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Phospholipase DThere is a great need of improved anticancer drugs and corresponding drug carriers. In particular, liposomal drug
carriers with heat-activated release and targeting functions are being developed for combined hyperthermia and
chemotherapy treatments of tumors. The aim of this study is to demonstrate the heat-activation of liposome
targeting to biotinylated surfaces, in model experiments where streptavidin is used as a pretargeting protein.
The design of the heat-activated liposomes is based on liposomes assembled in an asymmetric structure and
with a deﬁned phase transition temperature. Asymmetry between the inside and the outside of the liposome
membrane was generated through the enzymatic action of phospholipase D, where lipid head groups in the
outer membrane leaﬂet, i.e. exposed to the enzyme, were hydrolyzed. The enzymatically treated and puriﬁed li-
posomes did not bind to streptavidin-modiﬁed surfaces. When activation heat was applied, starting from 22 °C,
binding of the liposomes occurred once the temperature approached 33± 0.5 °C.Moreover, it was observed that
the asymmetric structure remained stable for at least 2 weeks. These results show the potential of asymmetric
liposomes for the targeted binding to cell membranes in response to (external) temperature stimulus. By using
pretargeting proteins, this approach can be further developed for personalized medicine, where tumor-speciﬁc
antibodies can be selected for the conjugation of pretargeting agents.
© 2015 Published by Elsevier B.V.1. Introduction
Liposomal systems have been intensively studied for their capacity
to deliver therapeutic and diagnostic materials [1]. Currently, most of
the liposomal systems on the market have been formulated to reduce
the systemic toxicity of the encapsulated drug and to extend the drug
circulation time after administration [2,3]. Newer formulations are
being designed to increase accumulation of the drug at the desired
sites by integrating target recognition molecules on the liposome
surfaces [4,5]. Although all of these approaches have potential therapeu-
tic value, further improvements are desired to obtain additional clinical
beneﬁts. Liposome systems that exhibit a stimuli-responsive property
(e.g., in response to temperature [6], or redox reactions [7]) have been
designed to improve cellular uptake, and thus will increase the drug
residence time at the target site by controlling the appearance of the
targeting molecules. A recently applied variant of targeting in oncology
is the so-called pretargeting, where bi-speciﬁc protein conjugates are
administrated before the delivery of the radioactive therapeutic agents
[8,9]. The streptavidin–biotin interaction used in pretargeting strategies
can be utilized for the delivery of biotinylated liposomes.
Temperature-responsive liposomes offer the possibility of enhancing
the therapeutic efﬁciency in hyperthermia treatments [10–12]. Stabilityem).against leakage is achieved at temperatures where liposomes remain in
the gel phase, and the encapsulated materials can be released when
the temperature is raised to the phase-transition regime. More pharma-
ceutical advantages are likely to be obtained if the temperature-
responsive liposomes can also change their surface properties upon
heat stimulus, in which the targeting function is activated as well as
the release. This concept has previously been shown for polymer-based
drug carriers [13].
As a tool to develop more advanced liposomes, the study of surface-
supported lipid membranes can provide valuable information on how
to design temperature-activated liposomal functions. For example, the
asymmetry of supported membranes can be studied as a function of
temperature [14–17], suggesting that membrane asymmetry can
potentially facilitate the positioning-control of ligand-modiﬁed lipids.
A commonly used strategy for preparing asymmetric supported lipid
membranes is the Langmuir–Blodgett (LB) technique [18]. However, it
cannot be applied as a protocol to produce asymmetric liposomes in
bulk solution. A more general strategy to generate asymmetry is by
hydrolyzing lipids in the presence of enzymes such as phospholipase
D (PLD). PLD is involved in a variety of cellular functions, one of which
is to catalyze the hydrolysis of lipid head groups to form phosphatidate
(PA) [19], as shown in Fig. 1A. Hidden surface functions in the
asymmetricmembranes can be activated by increasing the temperature
close to the gel to liquid-crystalline phase-transition temperature
(Tm = 41 °C for DPPC lipids) of the asymmetric membrane where
lipid ﬂip-ﬂop appears.
Fig. 1. (A) Chemical structures of the lipids used in the present study. (B) Schematic representation of the preparation of the asymmetric liposomes.
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biotinylated lipids originally hidden in the lower leaﬂet of a supported
lipid membrane prepared using sequential deposition of the lipid
leaﬂets in situ [16]. Here, we take advantage of PLD to prepare
asymmetric liposomes through hydrolysis of lipid head groups at the
outer membrane leaﬂet while leaving the functionality of the lipids in
the hidden leaﬂet, assuming that the asymmetry is maintained below
the phase transition temperature.
With the aim to demonstrate heat-activation of liposome binding to
a target model surface, the present protocol is ﬁrst developed using
supported lipid membranes as a model system, and then applied to
liposomes. The supported biotinylated membranes are also used as a
biomimetic platform for the investigation of the temperature depen-
dence of liposome binding. Streptavidin binds highly speciﬁcally and
with high afﬁnity to biotinylated lipids, and can be used as a
pretargeting agent to label the targeted surfaces, here by attracting
liposomes when biotin-lipids ﬂop to the surface.The protocol development using supported membranes as well as
the binding of targeted liposome were monitored by the quartz crystal
microbalance with dissipation (QCM-D) technique.2. Materials and methods
2.1. Materials
Chemicals were purchased from commercial suppliers and used
without further puriﬁcation unless otherwise stated. 1, 2-Dipalmitoyl-
sn-glycero-3-phosphatidylcholine (DPPC), 1, 2-dipalmitoyl-sn-glycero-
3-phosphoethanolamine-N-(biotinyl) (DPPE-biotin), 1-palmitoyl-2-
oleoyl-sn-glycero-3-phosphocholine (POPC), and 1, 2-dioleoyl-sn-
glycero-3-phosphoethanolamine-N-(biotinyl) (DOPE-biotin) were
purchased from Avanti Polar Lipids Inc., USA. Phospholipase D (PLD)
and streptavidin were purchased from Sigma.
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purify water to a minimum resistivity of 18.2 MΩ·cm. Tris-buffered
saline containing 10 mM Tris, and 100 mM sodium chloride (NaCl)
was prepared in water. The pH of the Tris buffer was adjusted to 8.0
by adding 0.1 M HCl solution, and the buffer was ﬁltered through
0.2 μm ﬁlters and degassed prior to use. Streptavidin was dissolved in
Tris buffer (50 μg/mL) and PLD was dissolved in water (1 mg/mL) and
further diluted in Tris buffer, of which the pH had been lowered to 5.5
by addition of HCl.
2.2. Liposome preparation and characterization
DPPC/DPPE-biotin liposomes were prepared by the following
procedure: 1 mg of DPPC and 10 μg of DPPE-biotin dissolved in metha-
nol were added to a round-bottomed ﬂask. The solvent was evaporated
under a gentle ﬂow of nitrogen in a fume hood, after which residual
methanol was removed under reduced pressure. The subsequent
rehydration and extrusion were performed at 55 °C, i.e., well above
the Tm for DPPC (Tm= 41 °C). The lipid ﬁlm was rehydrated by mixing
with 1mL Tris buffer, and the suspensionwas kept in anoven for at least
1 h with occasional vortex until lipids were fully dissolved. The solution
was then extruded through polycarbonate membranes with pore sizes
of 50 nm (Whatman, UK) 51 times in a temperature controlled mini-
extruder (Avanti Polar Lipids, USA). POPC/DOPE-biotin liposomes
were prepared following the same protocol, but at an ambient
temperature.
The asymmetric liposomes were prepared by incubating 0.1 mg
extruded DPPC/DPPE-biotin liposomes (symmetric) with 25 units
(100 μL) PLD in 380 μL Tris solution at pH 5.5 at ambient temperature
for 30 min. The suspension was then ﬁltered through an Amicon Ultra
−0.5 mL centrifugal ﬁlter (100 K) (Merck Millipore, IRL) at 14,000g
for 3 min, followed by 4 times washing with Tris buffer (pH 8) to sepa-
rate the liposomes from PLD, the cleaved biotin derivative and choline.Fig. 2. (A) Streptavidin binding to supported symmetric and asymmetric DPPC/DPPE-biotin
asymmetric membrane and the heat-induced biotin lipid ﬂopping and binding to streptavidin.The asymmetric liposomeswere collected by spinning theﬁlter reverse-
ly at 1000g for 2 min. The ﬁltered liposome solution was diluted to a
concentration of 0.02 mg/mL for further measurements. The recovery
of the liposome was calculated by measuring the concentration of
liposomes and PLD using a UV/visible spectrophotometer (JENWAY,
UK). The absorbance at 400 nm and 280 nm were used to determine
the concentration of liposomes and proteins respectively.
Both symmetric and asymmetric liposomes were characterized by
dynamic light scattering (DLS) (Malvern, UK) with respect to size and
zeta potential. The polydispersity index (PDI) was used to estimate
the size distribution of the liposomes. Measurements were carried out
at room temperature using liposome solutions that were diluted in
Tris buffer to 0.02 mg/mL. For liposome zeta potential measurements,
liposome solutions were diluted in water to a concentration of
0.02 mg/mL and the measurements were repeated 5 times at 22 °C.2.3. Quartz crystal microbalance with dissipation (QCM-D) measurements
The preparation of supported asymmetric lipid membranes
and the subsequent transmembrane lipid exchange (ﬂip-ﬂop), as
well as the binding of heat-activated asymmetric liposomes to
immobilized streptavidin layers, were monitored by QCM-D and
repeated at least 4 times for each case. Prior to mounting, the
QCM-D crystals (SiO2-coated sensors obtained from Q-Sense AB,
Sweden) were rinsed with ethanol and water, and then cleaned in
a UV-ozone cleaner for 30 min. QCM-D measurements were per-
formed at several harmonics (3, 5, 7, 9, 11, and 13) using a QCM-D
E4 system (Q-Sense AB, Sweden). The frequency and dissipation
shifts were plotted using the Q-tools software (Q-Sense AB,
Sweden). The presented frequency shifts obtained at different
overtones were normalized by dividing each frequency shift by the
corresponding overtone number.membranes as detected by QCM-D. (B) Schematic representation of the formation of
Fig. 3. Size distributions of the symmetric, asymmetric, and heat-treated asymmetric
liposomes (0 days).
Table 1
Average size, size distribution and zeta potential of the symmetric, asymmetric, and heat-treated asymmetric liposomes.
Storage time Symmetric liposomes Asymmetric liposomes Heat-treated
Asymmetric liposomes
+0 days Zeta potential (μV) −3 ± 1 −44 ± 6 −30 ± 7
Average diameter (nm) 92 ± 1 126 ± 3 134 ± 7
PDI 0.031 ± 0.005 0.103 ± 0.010 0.121 ± 0.011
+7 days Zeta potential (μV) −4 ± 2 −49 ± 5 −32 ± 6
Average diameter (nm) 93 ± 2 126 ± 3 136 ± 8
PDI 0.031 ± 0.005 0.108 ± 0.006 0.120 ± 0.003
+14 days Zeta potential (μV) −5 ± 1 −51 ± 7 −33 ± 4
Average diameter (nm) 93 ± 1 129 ± 3 136 ± 1
PDI 0.031 ± 0.005 0.108 ± 0.006 0.113 ± 0.011
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was carried out as follows: DPPC/DPPE-biotin liposomes (0.2 mg/mL)
were adsorbed onto SiO2 QCM-D crystals at 50 °C and formed supported
DPPC/DPPE-biotin membranes. After stabilization of the QCM-D signals
at −25 Hz and b 0.5 × 10−6, which are characteristic values for a
supported lipid membrane [20,21], the temperature was decreased to
22 °C. PLD was then introduced, and after the ﬂow had been stopped
the membranes were incubated with PLD for 1 h. The hydrolysis was
interrupted by removal of the enzyme by rinsing with Tris buffer. The
temperature was then increased to 43 °C and maintained for 1 h to
allow the lipids to redistribute between the two leaﬂets. Before the
heat-activation, streptavidin (50 μg/mL) solution was injected to
probe the presence of biotinylated lipids at the outermembrane surface.
The ﬂow was then stopped and the temperature was increased follow-
ing a linear gradient. The streptavidin solution left above the sensors
was used to demonstrate the reappearance of the biotinylated lipid on
the upper leaﬂet.
The experiment was performed as follows for the investigation of
heat-activated asymmetric liposome adsorption on streptavidin layers:
two parallel experiments were carried out in two sensors where POPC/
DOPE-biotin liposomes (diluted just before injection to a total lipid
concentration of 0.2 mg/mL in Tris buffer) were adsorbed onto SiO2
QCM-D crystals at 22 °C to form supported lipidmembraneswith biotin.
Streptavidin was immobilized onto the membrane, followed by rinsing
with Tris buffer. Symmetric liposomes (0.1 mg/mL) were introduced to
the immobilized streptavidin layers. At the same time, the ﬁltered
asymmetric liposomes (0.1 mg/mL) were added to the other sensor,
then the ﬂow was stopped after 10 min. The temperature was again
increased to 43 °C and maintained for 1 h. The temperature-induced
effects on the QCM-D signal shifts were removed by subtracting the
signals from reference measurements performed using the same blank
crystals exposed to buffer under the same conditions (as described in
[22] and [23]).
In order to evaluate the stability of the asymmetric liposomes, the
experiments were repeated after 7 days and 14 days.
3. Results and discussion
3.1. Development of the protocol: ﬂip-ﬂop in supported asymmetric lipid
membranes
As a ﬁrst step towards the preparation of asymmetric liposomes, we
investigated whether asymmetric lipid membranes could be prepared
on silica-coated QCM-D sensors where the head groups of lipids in
the upper leaﬂet of symmetric membranes were hydrolyzed into
phosphatidate through the action of PLD.
Our strategy to form a supported lipidmembranewith an asymmet-
ric structure is shown in Fig. 2. The spontaneous rupture of DPPC/DPPE-
biotin liposomes at 50 °C is followed by well-established pathway as
shown in more detail in the left part of Fig. 2(A), frequency decreased
(mass increase) and dissipation increased during the adsorption of
intact liposomes, reaching a minimum in frequency (maximum inmass) and maximum in dissipation. A subsequent rise in frequency
and a decrease in dissipation then occurred, when the layer of
supported liposomes transformed into a supported membrane. The
spontaneous liposome rupture started when the critical coverage of
liposomes on the silica surface had been reached [20,24]. When the
signals had reached the expected values [20] (Δf = −25 Hz and
ΔD = 0. 2 × 10−6 after 5 min in Fig. 1), the temperature was
decreased to 22 °C (far below the Tm of the membrane, thus lipids
were in the gel phase) in order to “freeze” the transmembrane
motions (ﬂip-ﬂop) of the lipids. Hydrolysis of the lipids in the
upper leaﬂet was initiated by the addition of PLD at 60 min, see in
Fig. 2 (no signal shifts indicated that no PLD was bound to the
surface), and was maintained for 1 h. It is suggested by the QCM-D
curves that the membrane remained intact. The change in mass on
the sensor surface (hydrolyzed choline and biotinylated ethanol-
amine, molecular weights are 104 Da and 305 Da respectively) was
too small to be detected.
The heat-activated asymmetric membrane surface function (i.e., to
induce membrane afﬁnity to streptavidin) was demonstrated by the
binding of streptavidin to biotinylated lipids. Those were preserved in
the lower leaﬂet and then ﬂopped-up to the upper one during heating
by applying a linear gradient from 22 °C to 43 °C for 1 h. Saturated
adsorption of streptavidin on symmetric membranes (not exposed to
PLD) was observed (120 min in Fig. 2). For the asymmetric membrane
at ambient temperature, the QCM-D signals did not respond to the addi-
tion of streptavidin at the same time. It showed that biotinylated lipid
head groups had been removed on the PLD-treatedmembrane surfaces.
In contrast, distinct streptavidin binding was detected during the tem-
perature increase (190min, 33 °C). The stabilized signals of streptavidin
bound to the ‘activated’ membrane corresponded to half of a saturated
layer of streptavidin, similarly to our previously published observation
[16]. The lowering of the dissipation signals after 220 min was likely
caused by difﬁculties related to the reference subtraction, but could
also indicate rearrangements in the layer on the surface.
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in supported DPPC/DPPE-biotin membranes can be generated and
preserved at ambient temperature. In the next step, the protocol
developed using the supported model membranes was applied for the
preparation of asymmetric liposomes.3.2. Preparation and characterization of the asymmetric liposomes
Asymmetric DPPC/DPPE-biotin liposomes were prepared by incu-
bating DPPC/DPPE-biotin liposomes with PLD in a Tris solution at
pH 5.5 for 30 min. The puriﬁcation of the liposomes was done with an
Amicon ﬁlter. PLD was detected based on the absorbance at 280 nm in
the ﬁltrate for the ﬁrst 4 times of centrifugation. The concentration of
PLD decreased until undetectable for the last washing. AsymmetricFig. 4. (A) Binding of symmetric and asymmetric DPPC/DPPE-biotin liposomes to a streptavidin-
biotin-lipid ﬂopping to the surface of asymmetric liposomes and binding to streptavidin. Noteliposomes were prepared with a yield of 78%, and no PLD could be
detected in the recovered solution.
No precipitation was observed in the suspensions due to the electric
repulsion between the hydrolyzed highly negatively charged PA lipids
presented on the outer leaﬂet of the asymmetric liposomes. The surface
of the asymmetric, PLD-treated liposomes had a lower zeta potential
compared to the symmetric liposomes, as shown in Table 1. An increase
in the zeta potential of the heat-treated asymmetric liposomes indicat-
ed that the number of negatively charged PA lipids decreased in the
outer leaﬂet. PA lipids diffused inwards to the inner leaﬂet, and neutral
PC lipids ﬂipped outwards. The change in surface properties of the
asymmetric liposomes after the heat treatment is a proof of the redistri-
bution of lipids, the zeta potential of the liposomes increased due to
lipid exchange between the neutral inner and negatively charged
outer leaﬂets.modiﬁed surface as detected byQCM-D. (B) Schematic representation of the heat-induced
that the size of the liposome is not to scale.
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monitoring of the liposome size and size distribution over time, as
shown in Table 1. Symmetric liposomes maintained their structural
characteristics through storage at 4 °C for more than 14 days. The
asymmetric liposomes remained intact after the ﬁltration and the heat
treatment. However, the size as well as size distribution of the
asymmetric liposomes was larger compared to that of the symmetric
ones, as shown in Fig. 3. We assumed that this was caused by the fusion
of liposomes during PLD hydrolysis or aggregation during centrifuga-
tion. The heat-treated asymmetric liposomes did not change signiﬁcant-
ly during the 2-week-experiment.
3.3. Heat-activation of asymmetric liposomes: targeting to streptavidin
layer
The heat-induced transition in asymmetry of the asymmetric
liposomes was veriﬁed by the binding of the liposomes onto
streptavidin-modiﬁed surfaces, as visualized in Fig. 4. The supported
POPC/DOPE-Biotin lipid bilayers did not contribute to the signal shifts.
The melting temperature of the supported membrane was −2 °C
which was well below the room temperature, and the membrane
remained in the liquid phase when temperature raised. Upon heat-
activation, liposomes transformed from the gel phase to the liquid-crys-
talline phase where biotinylated lipids that were originally ‘frozen’ in
the inner leaﬂet of the asymmetric liposomes ﬂopped outwards and
PA lipids in the outer leaﬂet ﬂipped inwards. As the ligands (biotin)
reappeared on the surface of the asymmetric liposomes, binding to the
streptavidin-modiﬁed surface could be observed. As described in
Section 2.2, streptavidin layers were immobilized to the sensor surfaces
at t = 25 min. Symmetric liposomes and asymmetric liposomes were
then introduced to the surface of streptavidin layers. From the frequen-
cy decrease and signiﬁcantly increased dissipation at t=30min,we can
observe that symmetric DPPC/DPPE-biotin liposomes started to bind to
streptavidin layers. On the contrary, asymmetric liposomes exhibited no
signal shift due to their inert surface. For the asymmetric liposomes, the
ﬂows were stopped at 40 min. At t = 110 min, the temperature was
raised at a rate of 0.35 °C/min and at 141 min (33 °C) the liposomes
began to attach to streptavidin layer as evident from the decreased
frequency. The onset temperature of binding (33 ± 0.5 °C) did not
change with respect to prolonged storage period (7 days and 14 days).
However, lipid ﬂip-ﬂop appears earlier than the melting temperature
Tm = 41 °C for DPPC. It can be hypothesized that the changes in
mechanical property (soften) at around 33 °C (pre-melting in the
process of phase transition [16,25]) will facilitate ﬂip-ﬂop, which corre-
sponds well with previous results [22]. In addition, the heat-activation
of lipid ﬂip-ﬂopwas veriﬁed by studying the stability of the asymmetric
liposomes against streptavidin when heat was applied in bulk. The size
of mixed asymmetric liposomes (0.02 mg/mL) and streptavidin
(0.1 mg/mL) solution was measured by DLS, and aggregation was ob-
served when the mixture was incubated at 43 °C for 30 min in a water
bath.
In summary, with the aim to show heat-activated binding of
liposomes to a target surface, we prepared asymmetric supported lipid
membranes in-situ and asymmetric liposomes in bulk solution. The
asymmetry in the model membranes, both when supported on a solid
surface and in liposomes, was well-preserved at room temperature
where lipids were in their gel state. Heat-activated liposome targeting
to the streptavidin-modiﬁed surfaces was identiﬁed at 33 ± 0.5 °C.
The activation temperature was repeatedly examined after the puri-
ﬁcation of the liposomes and after storage in room temperature for
7 days. Stability was also veriﬁed by uniform characteristics of the
asymmetric liposomes during the storage period. The described
asymmetric liposomal system offers an interesting approach for the
development of targeted liposome delivery under heat stimulus.
This method has the potential to improve diagnostic imaging and
drug delivery, where lipid membranes can alter their surface afﬁnityto targeted sites in response to temperature changes under hyper-
thermic conditions. However, due to the disturbance in lipid diffu-
sion at the pre-phase transition at around 33 °C, the transition
temperature is lower than the expected temperature for hyperther-
mia application (39 °C to 42 °C). In order to improve the targeting
performance, a higher transition temperature is therefore required.
This can be achieved by incorporation of lipids with higher phase-
transition temperature into the liposome. The formation of the
pretargeting layer of protein on supported membranes and further
attachment of the liposomes are monitored by QCM-D in real time,
which can be developed as an in-vitro platform for the investigation
of targeted delivery of drug carriers. Further modiﬁcations are inter-
esting to study, where the biotin functional group is replaced by an-
other targeting ligand.4. Conclusions
In conclusion, we report on the use of asymmetric model mem-
branes as a useful tool for the development of liposomal drug carriers
with temperature-activated surface properties. Asymmetric liposomes
were prepared based on selective phospholipase hydrolysis of lipid
head groups in the outer leaﬂet of symmetric liposomes. The asymme-
try of the liposomes was maintained in the gel phase. Flopping of the
biotinylated lipids from the inner to the outer leaﬂet of the asymmetric
liposomes was induced by raising the temperature close to the gel to
liquid-crystalline phase-transition temperature of the lipid membrane,
as demonstrated by controlled binding of asymmetric liposomes to tar-
get surfaces in experiments with deﬁned temperature gradients.Transparency document
The Transparency document associated with this article can be
found, in the online version.Acknowledgements
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